Earnings summaries and quarterly performance for NASDAQ.
Executive leadership at NASDAQ.
Adena Friedman
Chair and Chief Executive Officer
Bradley Peterson
Executive Vice President and Chief Information Officer/Chief Technology Officer
Bryan Smith
Executive Vice President and Chief People Officer
Jeremy Skule
Executive Vice President and Chief Strategy Officer; Executive Chair, Financial Crime Management Technology
John Zecca
Executive Vice President and Chief Legal, Risk and Regulatory Officer
Michelle Daly
Senior Vice President and Controller and Principal Accounting Officer
Nelson Griggs
President
Sarah Youngwood
Executive Vice President and Chief Financial Officer
Tal Cohen
President
Board of directors at NASDAQ.
Alfred Zollar
Director
Charlene Begley
Director
Essa Kazim
Director
Holden Spaht
Director
Jeffery Yabuki
Director
Johan Torgeby
Director
Kathryn Koch
Director
Melissa Arnoldi
Director
Michael Splinter
Lead Independent Director
Thomas Kloet
Director
Toni Townes-Whitley
Director
Research analysts who have asked questions during NASDAQ earnings calls.
Alexander Blostein
Goldman Sachs
6 questions for NDAQ
Ashish Sabadra
RBC Capital Markets
5 questions for NDAQ
Benjamin Budish
Barclays PLC
5 questions for NDAQ
Brian Bedell
Deutsche Bank
5 questions for NDAQ
Michael Cyprys
Morgan Stanley
5 questions for NDAQ
Owen Lau
Oppenheimer & Co. Inc.
5 questions for NDAQ
Alex Kramm
UBS Group AG
4 questions for NDAQ
Patrick Moley
Piper Sandler & Co.
4 questions for NDAQ
Craig Siegenthaler
Bank of America
3 questions for NDAQ
Dan Fannon
Jefferies & Company Inc.
3 questions for NDAQ
Daniel Fannon
Jefferies Financial Group Inc.
3 questions for NDAQ
Jeff Schmitt
William Blair & Company, L.L.C.
3 questions for NDAQ
Kyle Voigt
Keefe, Bruyette & Woods
3 questions for NDAQ
Michael Cho
JPMorgan Chase & Co.
3 questions for NDAQ
Eli Abboud
Bank of America
2 questions for NDAQ
Simon Clinch
Redburn Atlantic
2 questions for NDAQ
William Katz
TD Cowen
2 questions for NDAQ
Y. Cho
JPMorgan Chase & Co.
2 questions for NDAQ
Alexander Kramm
UBS Group AG
1 question for NDAQ
Ben Budish
Barclays PLC
1 question for NDAQ
Brian Bertram Bedell
Deutsche Bank AG
1 question for NDAQ
Christopher Allen
Citigroup
1 question for NDAQ
Jeffrey Schmitt
William Blair
1 question for NDAQ
Kwun Sum Lau
Oppenheimer
1 question for NDAQ
Simon Alistair Clinch
Redburn Atlantic
1 question for NDAQ
Recent press releases and 8-K filings for NDAQ.
- In 2025, IBKR retail clients returned 19.20% vs 17.9% for the S&P 500, while IBKR hedge fund clients achieved 28.91%, outperforming the index by approximately 11 points.
- Clients earned up to 3.14% on uninvested cash balances and margin rates as low as 4.14%, up to 55% below industry averages, enhancing net returns.
- The platform offers access to more than 160 international markets, enabling diversified exposure across regions and asset classes.
- Professional-grade execution tools, including sophisticated order types and smart routing, support efficient trade execution and risk management.
- Profusa partners with French distributor MedSell to commercialize its Lumee Oxygen tissue monitoring in hospitals and outpatient wound care clinics across France.
- The new agreement expands Profusa’s existing network in Spain, Germany, the Benelux, Austria, the UK, and Scandinavia, collectively addressing approximately 200,000 annual CLI cases in the EU.
- This distribution deal complements Profusa’s collaboration with Prof. Yann Gouëffic at Groupe Hospitalier Paris Saint Joseph, covering about 8% of France’s CLTI cases.
- Record user engagement in Q4 2025: Steam peak concurrent users hit 12,800 for the Maiden Voyage update, Bellwright sold over 150,000 units, ARK: Ultimate Mobile Edition surpassed 1,000,000 downloads, and the Survival Ascension DLC peaked at 46,900 CCU.
- Multi-year content roadmap announced: detailed ARK releases through 2027, including titles such as FF: Survival Ascension, Bob’s True Tales: Tides of Fortune, ARK: World Creator, ARK: Atlantis and ARK: Legacy of Santiago Part 1.
- Digital payment and tokenization initiatives: launched the USDO stablecoin and introduced the "Golden Poop" collectible token to explore new community-driven payment solutions.
- BullFrog AI highlighted a commercial collaboration with Sygnature Discovery initiated in Q2 2025, expected to generate significant revenue through 2028.
- The company launched BullFrog Data Networks™, an enterprise-grade AI platform, and bfPREP™, its AI-powered data preparation module, to accelerate adoption in drug development workflows.
- It demonstrated real-world validation in a Phase 3 oncology program with Eleison Pharmaceuticals; results will be publicly presented at ASCO in January 2026.
- BullFrog AI maintained capital discipline with an annual burn of approximately $6.2 million, plus a $10 million equity line and ATM, supporting runway and 2026 growth catalysts.
- Core payment infrastructure is largely in place, positioning the company for enterprise-scale stablecoin activation beginning in 2026 while legacy businesses continue to provide stability.
- Total revenue reached US$3.84 million in the first half of 2025, up from US$3.61 million a year earlier; payment services revenue rose 16% to US$2.17 million, and OwlNest revenue grew ~20%.
- Gross profit was US$480 thousand (12.5% margin) versus US$540 thousand (15.0% margin) in H1 2024, reflecting a shift toward traditional payment channels.
- Operating expenses totaled US$6.79 million, driven by one-time listing‐related costs; the net loss narrowed to US$3.91 million from US$5.35 million in H1 2024.
- Operating cash outflows improved to US$1.29 million, down from US$4.45 million in the prior‐year period, reflecting stronger revenue and cost efficiencies.
- Xeriant’s Factor X Research Group aims to accelerate innovations in green construction (projected at $1.8 trillion by 2030) and post-quantum cryptography (39.21% CAGR to $4.6 billion by 2030) through a Skunk Works-style R&D hub.
- Society Pass launches TMG Social, a live commerce platform in Thailand targeting Southeast Asia’s $90 billion social commerce market, leveraging a 10,000+ influencer network and aiming for $10 million in 2026 revenue.
- Adlai Nortye enters an exclusive Greater China licensing deal for its pan-RAS inhibitor AN9025, with total consideration of up to RMB 1.6 billion (~$230 million), including over $20 million in upfront and near-term milestones.
- SoftBank is exploring a potential acquisition of DigitalBridge, which manages over $100 billion in digital infrastructure assets across data centers, fiber, towers, and edge networks.
- Brand Engagement Network secures a custom AI engagement project for a top-10 global pharma, expecting $250,000 in Q4 2025 development revenue and recurring license fees beginning in Q1 2026.
- Terminated its open $15 million Equity Line of Credit effective December 22, 2025, with no further purchases or puts executed.
- Move is intended to avoid further shareholder dilution and underscore the company’s strong balance sheet focus.
- As of year-end 2025, IP Strategy holds 53.2 million $IP tokens as a primary reserve asset.
- The National Medical Products Administration approved neffy® 2 mg nasal spray for emergency treatment of Type I allergic reactions (anaphylaxis) in adults and children ≥30 kg, marking it as the first community use epinephrine product in China; availability expected spring 2026.
- Under a 2021 exclusive license, ARS Pharma will supply neffy to Pediatrix Therapeutics at cost and receive a $4 million regulatory milestone plus up to $80 million in sales milestones and low-double-digit royalties.
- An estimated 50–100 million people in China are at risk for severe food allergies and anaphylaxis, highlighting a substantial unmet need for accessible epinephrine treatment outside hospital settings.
- REE Automotive entered a non-binding MOU with BorgWarner’s Cascadia Motion to co-develop and supply next-generation electric drive units (EDUs) that integrate REEcorner technology with the iM-125 inverter-motor module, under a royalty-bearing, time-limited exclusive distribution option and access to REE’s assembly line and tooling.
- The partnership builds on a three-year collaboration to accelerate global OEM electrification programs with compact, cross-platform EDUs designed for ASIL-D functional safety and secure OTA updates.
- Global EDU market is forecast to grow at a 9% CAGR from 2025 to 2035 and double in size by 2035, according to industry estimates.
- Combined EDU performance: 3000 Nm peak torque, 100 kW peak power, 2150 Nm continuous torque, and 54 kg weight, delivered via a 400 V permanent-magnet motor in a 19.17:1 gear ratio.
- Caterpillar has surged 61% YTD, becoming the Dow’s top performer as it pivots toward power-generation and AI-adjacent businesses.
- Average analyst price target implies about 1% upside, with CFRA analysts warning of “sky-high” expectations and stretched valuations.
- NXP Semiconductors and Deckers highlighted for weakening fundamentals, including sales declines, shrinking free-cash-flow margins, and below-industry operating margins.
- Israel’s TA-125 index is up 52% YTD, driven mainly by domestic retail buying, with turnover up over 50% and sector returns led by insurance, banks, and energy-infrastructure stocks.
- Promotional AI-energy pitches stress extreme energy consumption claims and position power and nuclear asset owners as “backdoor” AI plays.
Quarterly earnings call transcripts for NASDAQ.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more